Erik Dubberke, MD
Enriched profileProfessor of Medicine · Washington University School of Medicine in St. Louis
Erik Dubberke is Professor of Medicine at Washington University School of Medicine in St. Louis. OpenAlex indexes 373 publications with 18,789 citations (h-index 66); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Erik Dubberke, MD, is Professor of Medicine at Washington University School of Medicine in St. Louis, Division of Infectious Diseases. The public record shows 373 publications with 18,789 citations (h-index 66), centered on Clostridium difficile and Clostridium perfringens research, Nosocomial Infections in ICU, Microscopic Colitis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 12 companies, 6 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Open forum infectious diseases
- Top research focus: Clostridium difficile and Clostridium perfringens research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 167.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
Sponsor: Washington University School of Medicine
- TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment
Sponsor: Washington University School of Medicine
- Fecal Microbiota Transplantation (FMT) for MDRO UTI
Sponsor: Washington University School of Medicine
Industry payments
Updated 27 Aug 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20252 payments
- PFIZER INC.Program year20253 payments
- IDORSIA PHARMACEUTICALS US INCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Glycopeptide Antibacterial57.9%Vancomycin Hcl100%Part D<11 patientsCephalosporin Antibacterial42.1%Ceftriaxone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Multi-Omics Unit for Combating Antibiotic-Resistant Bacteria (MOCARB)
Washington University
FY2026$2,190,822P01AI197197 - Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients
Washington University
FY2026$919,820U01AI195139
Congress activity
Updated 27 Aug 2026
1 congress contribution (2022) across ASH per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Relationship Between Clostridioides difficile Stool Concentration, Nucleic Acid Amplification Test Results, and Environmental Contamination.
Open forum infectious diseases
Article2026 - Comparison of broad-spectrum anti-Pseudomonal beta-lactam antibiotics versus targeted therapy for neutropenic patients with methicillin-susceptible Staphylococcus aureus bloodstream infections.
Antimicrobial stewardship & healthcare epidemiology
Article2025 - Informing estimates of probability of Clostridioides difficile infection for testing and treatment: expert consensus from a modified-Delphi procedure.
Antimicrobial stewardship & healthcare epidemiology
Article2024 - Comparison of Clostridioides difficile nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs.
Journal of clinical microbiology
Article2024
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/erik-dubberke-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DNHTyIyR7IJ
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
infectiousdiseases.wustl.edu/people/erik-dubberke
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- Infectious Diseases Fellowship
Washington University School of Medicine/Barnes-Jewish Hospital, St. Louis, MO
2005verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - Board Certified
Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
Editorial & leadership roles
journal and society appointments- Lead/co-author
'Strategies to Prevent Clostridioides difficile Infections in Acute-Care Hospitals: 2022 Update' (SHEA/IDSA compendium)
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- Expert panel author/contributor
SHEA/IDSA 2017 Clinical Practice Guideline Update for Clostridium difficile Infection in Adults and Children
2017verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
Secondary affiliations
appointments beyond the home institution- Clinical Director
Transplant Infectious Diseases Consult Service, Washington University/Barnes-Jewish Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - Director of Infectious Diseases Epidemiology Research
Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - Associate Hospital Epidemiologist
Barnes-Jewish Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
Media & interviews
press, podcasts and appearances- Video presenter
'Costs of Care Considerations in Clostridium difficile' (YouTube, Peer Voice/education series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Video presenter
'Monitoring for Treatment Response in C. difficile' (educational video series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramaswamy Govindan, MD
Washington University School of Medicine in St. Louis
Marin Kollef, MD
Washington University School of Medicine in St. Louis
Mark Huffman, MD
Washington University School of Medicine in St. Louis
Brad Kahl, MD
Washington University School of Medicine in St. Louis